Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...

Prenuvo CEO Andrew Lacy sat down with pharmaphorum after their Frontiers Health keynote to discuss: ...

Anti-APRIL antibody Voyxact (sibeprenlimab) has been approved by the US regulator to reduce proteinuria in adults with ...

Reimbursement authority NICE has ruled that London-based Autolus' Aucatzyl (obecabtagene autoleucel or obe-cel) can be used ...

When applied responsibly, AI empowers medical, commercial, and access teams to make faster, evidence-based decisions and ...

Novo Nordisk said it will now move ahead with a phase 3 programme for both versions of the drug in adults with type 2 ...

Digital health is now an essential tool to scaling healthcare, but there are still many challenges to deploying it scalably ...

This video captures the essence of a very special 10th Anniversary Frontiers Health - visionary talks, groundbreaking ...

At Frontiers Health 2025, we spoke with Meri Beckwith (Lindus Health), Daniel Diezi (Gerresheimer), and David Benshoof Klein ...

The new intrathecal formulation means the one-shot gene therapy is now available to all SMA patients, regardless of their age ...

In a boost for the UK life sciences sector, a new life sciences hub located at Barts Health NHS Trust in London has opened ...

Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...